GGTI-2133

CAS No. 191102-79-1

GGTI-2133( —— )

Catalog No. M33985 CAS No. 191102-79-1

GGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 588 In Stock
10MG 905 In Stock
25MG 1416 In Stock
50MG 1841 In Stock
100MG 2567 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GGTI-2133
  • Note
    Research use only, not for human use.
  • Brief Description
    GGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.
  • Description
    GGTI-2133 is a direct and selective inhibitor of geran ylgeranyltransferase (GGTase). GGTI-2133 has the potential for eosinophilic airway inflammation such as asthma research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Transferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    191102-79-1
  • Formula Weight
    456.54
  • Molecular Formula
    C27H28N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N[C@@H](CC(C)C)C(O)=O)(=O)C1=C(C=2C3=C(C=CC2)C=CC=C3)C=C(NCC4=CN=CN4)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Eliglustat

    Eliglustat (Tartrate) inhibits?glucosylceramide synthase(GCS),thus reducing the load of glucosylceramide influx into the lysosome.

  • CBHcy

    CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.

  • OU749

    OU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.